Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with …
DJ Sargent, CH Köhne, HK Sanoff, BM Bot… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Performance status (PS) is a prognostic factor in patients with metastatic colorectal
cancer. Clinical trials typically enroll less than 10% of patients with a PS of 2 (PS2); thus, the …
cancer. Clinical trials typically enroll less than 10% of patients with a PS of 2 (PS2); thus, the …
[PDF][PDF] Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From …
DJ Sargent, CH Köhne, HK Sanoff, BM Bot… - Clinical …, 2007 - researchgate.net
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes
in Nine First-Line Treatment Trials U Page 1 Pooled Safety and Efficacy Analysis Examining the …
in Nine First-Line Treatment Trials U Page 1 Pooled Safety and Efficacy Analysis Examining the …
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients …
DJ Sargent, CH Köhne, HK Sanoff, BM Bot… - Journal of Clinical …, 2009 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Performance status (PS) is a
prognostic factor in patients with metastatic colorectal cancer. Clinical trials typically enroll …
prognostic factor in patients with metastatic colorectal cancer. Clinical trials typically enroll …
[HTML][HTML] Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From …
DJ Sargent, CH Köhne, HK Sanoff, BM Bot… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on
Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With …
Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With …
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with …
DJ Sargent, CH Köhne, HK Sanoff… - Journal of Clinical …, 2009 - ohiostate.elsevierpure.com
Purpose Performance status (PS) is a prognostic factor in patients with metastatic colorectal
cancer. Clinical trials typically enroll less than 10% of patients with a PS of 2 (PS2); thus, the …
cancer. Clinical trials typically enroll less than 10% of patients with a PS of 2 (PS2); thus, the …
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients …
DJ Sargent, CH Köhne, HK Sanoff, BM Bot… - Journal of Clinical …, 2009 - cdr.lib.unc.edu
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes
in Nine First-Line Treatment Trials U Page 1 Pooled Safety and Efficacy Analysis Examining the …
in Nine First-Line Treatment Trials U Page 1 Pooled Safety and Efficacy Analysis Examining the …
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with …
DJ Sargent, CH Köhne, HK Sanoff… - Journal of clinical …, 2009 - pubmed.ncbi.nlm.nih.gov
Purpose Performance status (PS) is a prognostic factor in patients with metastatic colorectal
cancer. Clinical trials typically enroll less than 10% of patients with a PS of 2 (PS2); thus, the …
cancer. Clinical trials typically enroll less than 10% of patients with a PS of 2 (PS2); thus, the …
[PDF][PDF] Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From …
DJ Sargent, CH Köhne, HK Sanoff, BM Bot… - Clinical …, 2007 - academia.edu
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes
in Nine First-Line Treatment Trials U Page 1 Pooled Safety and Efficacy Analysis Examining the …
in Nine First-Line Treatment Trials U Page 1 Pooled Safety and Efficacy Analysis Examining the …
[引用][C] Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From …
DJ SARGENT, CH KÖHNE… - Journal of clinical …, 2009 - pascal-francis.inist.fr
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on
Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With …
Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With …
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with …
DJ Sargent, CH Köhne, HK Sanoff… - Journal of Clinical …, 2009 - mayoclinic.elsevierpure.com
Purpose Performance status (PS) is a prognostic factor in patients with metastatic colorectal
cancer. Clinical trials typically enroll less than 10% of patients with a PS of 2 (PS2); thus, the …
cancer. Clinical trials typically enroll less than 10% of patients with a PS of 2 (PS2); thus, the …